Nonalcoholic fatty liver disease test: an external validation cohort

被引：0
作者：
Stergios A. Polyzos
Apostolis Papaefthymiou
Michael Doulberis
Jannis Kountouras
机构：
[1] Aristotle University of Thessaloniki,First Laboratory of Pharmacology, School of Medicine
[2] University College London Hospitals (UCLH),Pancreaticobiliary Medicine Unit
[3] Gastroklinik,Division of Gastroenterology and Hepatology, Medical University Department
[4] Private Gastroenterological Practice,Second Medical Clinic, School of Medicine
[5] Kantonsspital Aarau,undefined
[6] Aristotle University of Thessaloniki,undefined
[7] Ippokration Hospital,undefined
来源：
Hormones | 2024年 / 23卷
关键词：
CHA index; Index of NASH; NAFLD test; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Non-invasive index;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：131 / 136
页数：5
相关论文
共 157 条
  • [1] Polyzos SA(2020)Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitis Metabolism 111S 154203-801
  • [2] Kang ES(2019)The Global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis J Hepatol 71 793-37
  • [3] Boutari C(2023)A multi-society Delphi consensus statement on new fatty liver disease nomenclature J Hepatol 52 25-368
  • [4] Rhee EJ(2021)Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease Arch Med Res 147 155666-167
  • [5] Mantzoros CS(2023)Liver biopsy-based validation, confirmation and comparison of the diagnostic performance of established and novel non-invasive steatotic liver disease indexes: Results from a large multi-center study Metabolism 101 154005-181
  • [6] Younossi ZM(2019)Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study Metabolism 21 349-880
  • [7] Golabi P(2022)Non-invasive diagnosis and staging of non-alcoholic fatty liver disease Hormones (Athens) 63 161-757
  • [8] de Avila L(2014)Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease Metabolism 18 172-508
  • [9] Minhui Paik J(2020)Non-alcoholic fatty liver disease treatment in patients with type 2 diabetes mellitus; new kids on the block Curr Vasc Pharmacol 35 874-2013
  • [10] Srishord M(2023)Development and validation of nonalcoholic fatty liver disease test: a simple sensitive and specific marker for early diagnosis of nonalcoholic fatty liver disease Eur J Gastroenterol Hepatol 12 749-undefined
12345678910